Tandem Diabetes Care Inc (TNDM): who owns it and who trades it
As of Nov 16, 2026, TNDM insiders reported 3 open-market sales worth $36.9K and no purchases in the last 12 months, with 88% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christopher J Twomey (Director), with $32.6K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Tandem Diabetes Care
From the latest filingsOverall: more buying than selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns TNDM
273 funds and institutions reported TNDM shares worth $1.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 16.9%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 11.58M | 16.90% | $175M | +8% |
| Sessa Capital IM, L.P. | 5.10M | 7.44% | $77M | +8% |
| Vanguard Portfolio Management LLC | 4.30M | 6.27% | $64.9M | +8% |
| First Light Asset Management, LLC | 3.38M | 4.94% | $51.1M | +157% |
| Vanguard Capital Management LLC | 3.10M | 4.52% | $46.7M | +2% |
| State Street Corp | 2.85M | 4.16% | $43M | +7% |
| GW&K Investment Management, LLC | 2.57M | 3.75% | $38.8M | -4% |
| Jennison Associates LLC | 2.33M | 3.40% | $35.2M | +41% |
| Paradice Investment Management LLC | 2.02M | 2.95% | $30.5M | -1% |
| Jacobs Levy Equity Management, Inc | 2.01M | 2.93% | $30.3M | +32% |
| Freestone Grove Partners LP | 1.87M | 2.72% | $28.2M | +40% |
| Geode Capital Management, LLC | 1.80M | 2.63% | $27.2M | +7% |
| Driehaus Capital Management LLC | 1.79M | 2.61% | $27M | -22% |
| Citadel Advisors LLC | 1.74M | 2.53% | $26.2M | -21% |
| Millennium Management LLC | 1.31M | 1.91% | $19.8M | +72% |
| Woodline Partners LP | 1.31M | 1.91% | $19.7M | – |
| ArrowMark Colorado Holdings LLC | 1.30M | 1.90% | $19.6M | -58% |
| UBS Group AG | 1.15M | 1.67% | $17.3M | -44% |
| FMR LLC (Fidelity) | 976,432 | 1.42% | $14.7M | +37% |
| Royce & Associates LP | 900,590 | 1.31% | $13.6M | +29% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, TNDM insiders reported $0 of open-market purchases and $36.9K of sales. 88% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Christopher J Twomey | Director | Sale plan | 1,700 | $19.15 | $32.6K | Form 4 |
| Mar 17, 2026 | Mark David Novara | Vice president | Sale | 187 | $23.05 | $4.3K | Form 4 |
| Mar 5, 2026 | Mark David Novara | Vice president | Sale plan | 2 | $22.81 | $46 | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Christopher J Twomey | Director | – | $32.6K | Oct 27, 2026 |
| Mark David Novara | EVP & CHIEF COMMERCIAL OFFICER | – | $4.4K | Mar 17, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TNDM short interest
Very high short interest. 23.2% of TNDM shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 50%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 16.17M TNDM shares were sold short, 23.2% of the shares outstanding, up 7.2% from the report before. At the average daily volume of 2.12M shares, buying them all back would take about 7.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 16.17M | 23.24% | +7% | 2.12M | 7.6 |
| Oct 15, 2026 | 15.09M | 21.68% | +13% | 2.20M | 6.9 |
| Sep 30, 2026 | 13.37M | 19.21% | +7% | 2.55M | 5.2 |
| Sep 15, 2026 | 12.47M | 17.93% | +6% | 1.58M | 7.9 |
| Aug 31, 2026 | 11.75M | 16.89% | +11% | 1.44M | 8.2 |
| Aug 14, 2026 | 10.59M | 15.21% | -6% | 2.72M | 3.9 |
| Jul 31, 2026 | 11.24M | 16.41% | -14% | 1.71M | 6.6 |
| Jul 15, 2026 | 13.12M | 19.14% | +3% | 1.50M | 8.7 |
| Jun 30, 2026 | 12.73M | 18.58% | +17% | 2.26M | 5.6 |
| Jun 15, 2026 | 10.85M | 15.84% | -8% | 2.66M | 4.1 |
| May 29, 2026 | 11.79M | 17.20% | +9% | 2.84M | 4.2 |
| May 15, 2026 | 10.80M | 15.76% | +11% | 3.22M | 3.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded TNDM
Since Nov 17, 2024, 2 members of Congress reported 4 purchases and 1 sale of TNDM. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.
Purchases 4Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Oct 12, 2026 | Report |
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Apr 7, 2026 | Report |
| Sep 22, 2025 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | Oct 15, 2025 | Report |
| Mar 19, 2025 | Josh Gottheimer (D-NJ) | Sale | $1K–$15K | Joint | Apr 10, 2025 | Report |
| Mar 4, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Apr 7, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Tandem Diabetes Care company events
Tandem Diabetes Care filed 8 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- May 21, 2026LeadershipAt the Annual Meeting, the Company’s stockholders also approved the Company’s 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares of the Company’s common stock (Common Stock) authorized for issuance under the plan by 3,260,000 shares (as so amended, the… Filing
- May 15, 2026LeadershipMark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc., was notified that his employment with the Company is being terminated without cause. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Feb 27, 2026AgreementEntry into a Material Agreement. Filing
- Feb 19, 2026ResultsReleased financial results. Filing
- Dec 30, 2025RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Tandem Diabetes Care financials
Famous investors that hold TNDM
4 of the 50 well-known investors we track reported holding TNDM in their latest 13F filing. The largest position is Israel Englander's, worth $33.8M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 2.07M | $33.8M | 0.0% | +58% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.86M | $30.4M | 0.0% | +7% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 880,196 | $14.4M | 0.0% | +44% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 432,816 | $7.1M | 0.0% | +19% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named TNDM in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | BALYASNY ASSET MANAGEMENT L.P. | 13G | 5.2% |
| Nov 16, 2026 | BALYASNY ASSET MANAGEMENT L.P. | 13G | 5.2% |
| Nov 16, 2026 | Sessa Capital IM, L.P. | 13G/A | 0.6% |
| Nov 16, 2026 | Sessa Capital IM, L.P. | 13G/A | 0.6% |
| Nov 9, 2026 | THE GOLDMAN SACHS GROUP, INC. | 13G | 5.9% |
| Nov 9, 2026 | THE GOLDMAN SACHS GROUP, INC. | 13G | 5.9% |
Questions about Tandem Diabetes Care Inc (TNDM) stock
Who owns the most TNDM stock?
The largest reported owner of Tandem Diabetes Care Inc (TNDM) is BlackRock, Inc., with 16.9% of the company. In total, 273 funds and institutions reported holding TNDM at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are TNDM insiders buying or selling?
In the last 12 months, TNDM insiders reported no open-market purchases and 3 sales worth $36.9K. The latest trade was on Oct 27, 2026. See every trade.
What is the short interest in TNDM?
As of Oct 30, 2026, 16.17M TNDM shares were sold short, 23.2% of the shares outstanding, up 7.2% from the report before. At the average daily volume of 2.12M shares, buying them all back would take about 7.6 trading days (days to cover). See the history.
Have members of Congress traded TNDM?
Yes. 2 members of Congress reported 4 purchases and 1 sale of TNDM since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.
Which famous investors hold TNDM?
4 of the 50 well-known investors we track reported TNDM in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $33.8M. See all holders.
Executive pay
Tandem Diabetes Care's chief executive was paid a total of $6.9M for the year ended Dec 31, 2025, down 20% from $8.5M the year before. In the last 12 months, Tandem Diabetes Care's executives and directors bought no stock on the open market and sold $36.9K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.